- Email: [email protected]
Dow Water opens water technology centre in Spain
NEWS/EXCHANGE RATES Dow Water & Process Solutions offers a broad portfolio of ion exchange resins, reverse osmosis membranes, ultra filtration membranes and electrodeionisation products for industrial and municipal water, industrial process, pharmaceutical, power, residential water and waste and water reuse applications.
Dow Water opens water technology centre in Spain
D
ow Water & Process Solutions has officially opened the Global Water Technology Development Center at the Dow facilities in Tarragona, Spain (see Filtration Industry Analyst, August 2008 and March 2009). The state-of-the-art centre, which is designed to accelerate the commercialisation of Dow’s water technologies, was funded through a US$15 million Dow investment, along with grant subsidies from Spain’s Ministry of Science and Innovation. “This centre represents a significant investment for Dow. It’s a one-of-a-kind facility staffed with leading industry experts to meet one of the world’s most pressing needs – clean water,” said Ian Barbour, general manager, Dow Water & Process Solutions. “The central location is ideal to support our customers in the region and gives us access to the wide variety of water sources, including waste water and seawater, to support product development and performance testing in real world conditions.” Initial research efforts will focus on improving the quality of desalinated water; minimising costs and reducing energy consumption; extending the useful life of membranes; and increasing efficiency of materials.
For further information, visit www.dowwaterandprocess.com
Ahlstrom expands filtration material capacity in Tampere
A
hlstrom Corp is investing in additional filtration material capacity for gas turbine and high efficiency air applications at its facility in Tampere, Finland. “This capacity increase in Tampere is an important step for Ahlstrom’s Filtration Business Area and we are committed to grow with our global customers in power generation and high efficiency air markets. We understand the importance of efficient and flawless gas turbine plant operation and we have focused on building the right product portfolio of filter media to meet these needs,” said Fulvio Capussotti, vice president, Ahlstrom Advanced Filtration. The Ahlstrom investment will be completed by the end of September 2011. For further information, visit www.ahlstrom.com
Exchange Rates against the US Dollar Date: 20.6.2011 Country Australia
Rate A$0.95
Country Netherlands
Rate E0.70
Austria
E0.70
Norway
Belgium
E0.70
Philippines
Canada
C$0.98
Singapore
China
Yn6.47
South Africa
R6.79
DKK5.21
South Korea
KWn1078.75
Denmark
NOK5.53 Peso43.53 S$1.24
E0.70
E0.70
Spain
France
E0.70
Sweden
SEK6.40
Germany
E0.70
Switzerland
CHF0.84
Taiwan
T$28.92
Thailand
Bt30.52
Finland
India Italy Japan Malaysia
16
Filtration Industry Analyst
Rs44.91 E0.70 ¥80.21
UK
Rt3.03
USA
£0.62
Editorial Office: Elsevier Limited The Boulevard, Langford Lane Kidlington Oxford OX5 1GB United Kingdom Tel: +44 (0) 1865 843695 Fax: +44 (0) 1865 843973 Web: www.filtrationindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Publisher: Greg Valero E-mail: [email protected] Subscription Information An annual subscription to Filtration Industry Analyst includes 12 printed issues and online access for up to 5 users. Prices: 1176 for all European countries & Iran US$1319 for all countries except Europe and Japan ¥156 345 for Japan (Prices valid until 31 December 2011) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971 Email: [email protected], or via www.filtrationindustryanalyst.com. Subscriptions run for 12 months, from the date payment is received. Periodicals postage is paid at Rahway, NJ 07065, USA. Postmaster send all USA address corrections to: Filtration Industry Analyst, 365 Blair Road, Avenel, NJ 07001, USA Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/ or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) LImited 02207
US$1.00
June 2011
Dow Water opens water technology centre in Spain
D
ow Water & Process Solutions has officially opened the Global Water Technology Development Center at the Dow facilities in Tarragona, Spain (see Filtration Industry Analyst, August 2008 and March 2009). The state-of-the-art centre, which is designed to accelerate the commercialisation of Dow’s water technologies, was funded through a US$15 million Dow investment, along with grant subsidies from Spain’s Ministry of Science and Innovation. “This centre represents a significant investment for Dow. It’s a one-of-a-kind facility staffed with leading industry experts to meet one of the world’s most pressing needs – clean water,” said Ian Barbour, general manager, Dow Water & Process Solutions. “The central location is ideal to support our customers in the region and gives us access to the wide variety of water sources, including waste water and seawater, to support product development and performance testing in real world conditions.” Initial research efforts will focus on improving the quality of desalinated water; minimising costs and reducing energy consumption; extending the useful life of membranes; and increasing efficiency of materials.
For further information, visit www.dowwaterandprocess.com
Ahlstrom expands filtration material capacity in Tampere
A
hlstrom Corp is investing in additional filtration material capacity for gas turbine and high efficiency air applications at its facility in Tampere, Finland. “This capacity increase in Tampere is an important step for Ahlstrom’s Filtration Business Area and we are committed to grow with our global customers in power generation and high efficiency air markets. We understand the importance of efficient and flawless gas turbine plant operation and we have focused on building the right product portfolio of filter media to meet these needs,” said Fulvio Capussotti, vice president, Ahlstrom Advanced Filtration. The Ahlstrom investment will be completed by the end of September 2011. For further information, visit www.ahlstrom.com
Exchange Rates against the US Dollar Date: 20.6.2011 Country Australia
Rate A$0.95
Country Netherlands
Rate E0.70
Austria
E0.70
Norway
Belgium
E0.70
Philippines
Canada
C$0.98
Singapore
China
Yn6.47
South Africa
R6.79
DKK5.21
South Korea
KWn1078.75
Denmark
NOK5.53 Peso43.53 S$1.24
E0.70
E0.70
Spain
France
E0.70
Sweden
SEK6.40
Germany
E0.70
Switzerland
CHF0.84
Taiwan
T$28.92
Thailand
Bt30.52
Finland
India Italy Japan Malaysia
16
Filtration Industry Analyst
Rs44.91 E0.70 ¥80.21
UK
Rt3.03
USA
£0.62
Editorial Office: Elsevier Limited The Boulevard, Langford Lane Kidlington Oxford OX5 1GB United Kingdom Tel: +44 (0) 1865 843695 Fax: +44 (0) 1865 843973 Web: www.filtrationindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Publisher: Greg Valero E-mail: [email protected] Subscription Information An annual subscription to Filtration Industry Analyst includes 12 printed issues and online access for up to 5 users. Prices: 1176 for all European countries & Iran US$1319 for all countries except Europe and Japan ¥156 345 for Japan (Prices valid until 31 December 2011) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971 Email: [email protected], or via www.filtrationindustryanalyst.com. Subscriptions run for 12 months, from the date payment is received. Periodicals postage is paid at Rahway, NJ 07065, USA. Postmaster send all USA address corrections to: Filtration Industry Analyst, 365 Blair Road, Avenel, NJ 07001, USA Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/ or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) LImited 02207
US$1.00
June 2011